Warning! OUTDATED BROWSER DETECTED!   Please update your browser immediately for a better experience on this website. Learn More
21/xsl/MobileMenu.xsltmobileNave880e1541/WorkArea//http://www.rsna.org/TwoColumnWireframe.aspx?pageid=21268&ekfxmen_noscript=1&ekfxmensel=falsefalsetruetruetruefalsefalse102e880e1541_21_1008.0.0.0730truefalse
  • About RSNA
  • 2016 Report of the Secretary Treasurer

  •  

    RSNA membership is holding relatively steady with a slight decrease overall. In 2016, the Society accepted 6,107 new members.

    We annually promote membership in our Society to new radiology residents and medical students. Through this year's promotional efforts 4,459 radiology residents and medical students joined the RSNA (1,341 new Members-in-training, 2,170 new Corresponding Members-intraining, 192 Fellows, and 756 Medical Students).

    We are pleased to see our specialty’s future leaders taking advantage of the great opportunities offered to them through RSNA membership. Members-in-training and medical students do not pay dues, have free access to RSNA benefits like Online Education and myRSNA, are allowed free admission to the RSNA Scientific Assembly and Annual Meeting, and receive access to the journals Radiology and RadioGraphics or subscribe to the printed versions of the journals at a highly subsidized rate.

     

    RSNA RECORD OF MEMBERSHIP

     

    Active

    Assoc

    Med Stu

    MIT

    Cor.-MIT

    Retired

    Honorary

    Corresp

    Totals

    2016

    18,991

    1,801

    1,939

    10,639

    8,416

    5,749

    69

    6,396

    54,000

    2015

    19,412

    1,797

    1,795

    10,605

    8,608

    5,479

    69

    6,549

    54,314

       

    Net Decrease

     -314

    I regret to report the passing of the colleagues named below as of October 31, 2016. RSNA mourns their deaths while honoring their service to the health and well-being of the communities in which they practiced medicine.

    DECEASED RSNA MEMBERS FROM 11/1/15 - 10/31/16  

    Herbert L. Abrams, MD, Palo Alto, CA (R69)
    Torsten H. Almen, MD, Falsterbo, Sweden (M91)
    Kazys G. Ambrozaitis, MD, Chesterson, IN (R59)
    Sam B. Baker, MD, Evansville, IN (R80)
    James A. Baumgarten, MD, Fort Myers, FL (R64)
    Lewis M. Bobroff, MD, Suffern, NY (M71)
    Morton A. Bosniak, MD, New York, NY (R64)
    John D. Camp Jr, MD, Lake Havasu City, AZ (R64)
    George Candardjis, MD, Pully, Switzerland (R78)
    John J. Carolan, MD, Nevada City, CA (R71)
    Barbara E. Chick, MD, Glens Falls, NY (R66)
    Harry R. Claypool, MD, Tucson, AZ (R60)
    Marlene Dominguez, MD, Grand Rapids, MI (Z12)
    Frederick W. Engmann, MD, Mississauga, ON, Canada (R90)
    Howard E. Fink Jr, MD, Ormond Beach, FL (R63)
    Philip R. Frederick, MD, Salt Lake City, UT (R63)
    John A. Freeman Jr, MD, Osprey, FL (R85)
    Gerald W. Friedland, MD, Los Gatos, CA (R74)
    John W. Gardner, MD, East Wenatchee, WA (R86)
    Frederic H. Gerber, MD, Medina, WA (R71)
    Mikhail Gertsberg, MD, Hartford, CT (T13)
    Myron Gooley, MD, Decatur, IL (R60)
    Michael B. Gordon, MD, Boca Raton, FL (R77)
    Gary S. Greene, MD, Newtown Square, PA (M82)
    Josef Hallermeier, MD, Auerbach, Germany (M06)
    George Z. Heimbach, MD, Bethlehem, PA (R70)
    Samuel J. Hessel, MD, Scottsdale, AZ (R85)
    Andrzej Jesmanowicz, PhD, Milwaukee, WI (M89)
    John D. Kennedy, MD, Venice, FL (R87)
    Elzaneti A. Khalifa, MD, Munich, Germany (R90)
    Polly S. Kochan, MD, Narberth, PA (A84)
    Guido H. Landman, MD, PhD, Nuenen, Netherlands (R85)
    D'Arcy D. Lawrence, MD, Victoria, BC, Canada (R77)
    Marcel LeMay, MD, Montreal, QC, Canada (R90)
    Herman W. Lubetsky, MD, New York, NY (R60)
    Herbert R. Madry Jr, MD, Raleigh, NC (R71)
    Thomas S. McCay, MD, Jackson, MS (R78)
    John R. McIver, MD, West Vancouver, BC, Canada (R89)
    Donn G. Mosser, MD, Minneapolis, MN (R54)
    Harold R. Neitzschman Jr, MD, New Orleans, LA (M76)
    Robert E. O'Mara, MD, Tucson, AZ (R69)
    Jerald H. Pietan, MD, Jacksonville, FL (M78)
    Robert J. Robl, MD, Westminster, MD (R72)
    John D. Roger, MD, Ottawa, ON, Canada (R49)
    Josef Rosch, MD, Portland, OR (M87)
    Lindsay J. Rowe, MD, MS, Toronto, NSW, Australia (M99)
    Yukihiko Sato, MD, Obihiro, Hokkai, Japan (M97)
    Welland O. Short, MD, Mebane, NC (R82)
    Maria E. Silvestre, MD, Lisbon, Portugal (H91)
    John A. Smith, MD, Carmel, IN (R76)
    John C. Smith, MD, Fresno, CA (M78)
    Harwood N. Sturtevant, MD, Springfield, MO (R59)
    Anthony J. Tabacco, MD, Tiverton, RI (R54)
    Rosemary Toye, FRCR, Bromley, United Kingdom ( M98)
    David B. Waters, MD, Tulsa, OK (R82)
    Thomas J. White III, MD, Memphis, TN (R82)
    Ariel L. Williams, MD, Kaysville, UT (R82)
    Fred E. Wise Jr, MD, Charlotte, NC (R54)
    Barbara J. Wolfson, MD, Sarasota, FL (R78)

    FINANCIAL STATEMENTS

    The financial statements for the fiscal year ended June 30, 2016, reflect positive earnings for the Society.

    The Society continues to experience financial growth. This is a result of maintaining its revenue
    sources and at the same time controlling its expenses. The return on investments is especially
    important for the Society’s Research and Education Foundation, as its ability to fund grants is
    directly impacted by investment earnings.

    BKD LLP completed its annual audit of the Society's financial statements issuing an unmodified
    opinion, indicating that BKD LLP found no material differences to the financial information
    presented in the Society's year-end financial statements. In addition BKD LLP indicated to the
    Audit Committee that it did not find any material weaknesses in the Society's internal accounting
    procedures.

    The following Balance Sheet and Statement of Activities have been condensed from the year-end audit report prepared by BKD LLP, as of June 30, 2016. The detailed audited report is kept on file at the RSNA's headquarters: Radiological Society of North America, 820 Jorie Boulevard, Oak Brook, IL 60523. It is available for review there by members of the RSNA.

    Richard L. Ehman, MD 
    Secretary-Treasurer 

    Statement of Financial Position
    June 30, 2016

    ASSETS

     

    Cash and Short-Term Investments

    $14,748,437

    Receivables and Other Current Assets

    7,329,785

    Long-Term Investments  

    118,837,949

    Property, Furniture and Equipment

    21,339,436

    Total Assets

    $162,313,380

     

    Liabilities and Net Assets

     

    Accounts Payable and Short-Term Debt

    $6,543,378  

    Deferred Revenue

    23,559,863

    Long-Term Debt and Other Long-Term Liabilities

    567,699

    Net Assets:

     

      Unrestricted:

     

         Undesignated

    59,587,579

    Designated-Research and Education Foundation

    47,101,388

      Restricted:

     

        Temporarily restricted

    1,628,497

        Permanently restricted

    23,324,976

    Total net assets

    131,642,440

    Total Liabilities and Net Assets

    $162,313,380

     

    Statement of Activities
    Year ending June 30, 2016
     

    REVENUE

     

    Membership Services

    $6,253,272

    Publications and Educational Materials

    13,367,037

    Annual Scientific Assembly

    24,825,853

    Investment Earnings

    3,005,875

    Contributions

    2,548,620

    Total Revenue

    $50,000,657

     

    EXPENSES

     

    Membership Services

    $7,150,005

    Publications and Educational Materials

    16,567,686

    Annual Scientific Assembly

    14,872,550

    Research and Education Foundation

    5,146,205

    Depreciation

    1,291,399

    Total Expenses

    $45,027,845



    Excess of operating revenue over operating expenses

    $4,972,812

    Federal and state income tax expense           

    (119,834)

    Non operating income

    (131,488)

    Increase in net assets before unrealized gain (loss) on investments

    $4,721,490

    Unrealized gain (loss) on valuation of investments and interest rate swap

    (3,127,955)

     

    Increase in Net Assets

    $1,593,535

    Net Assets at beginning of year

    $130,048,905

    Net Assets at end of year

    $131,642,440

     

     Total Revenue 2016

    Total Expense 2016  

     

    Richard L. Baron, MD Secretary-Treasurer